About MetaModix
MetaModix is a company based in Plymouth (United States) founded in 2009. MetaModix has raised $5.21 million across 10 funding rounds. MetaModix offers products and services including EndoSleeve. MetaModix operates in a competitive market with competitors including Fractyl, GI Dynamics, EndObetes, Allevetix and ReBio, among others.
- Headquarter Plymouth, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Metamodix, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.21 M (USD)
in 10 rounds
-
Latest Funding Round
$100 K (USD), Series A
Jul 01, 2018
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MetaModix
MetaModix offers a comprehensive portfolio of products and services, including EndoSleeve.
Treatment device for Type 2 Diabetes, Obesity, and NASH.
People of MetaModix
Unlock access to complete
Unlock access to complete
Funding Insights of MetaModix
MetaModix has successfully raised a total of $5.21M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $100 thousand completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by MetaModix
Investment portfolio details for MetaModix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MetaModix
Detailed financials for MetaModix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metamodix Comparisons
Peer comparison for MetaModix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MetaModix
MetaModix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fractyl, GI Dynamics, EndObetes, Allevetix and ReBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| Locked | Locked | Locked |
Endoscopic barriers for diabetes and metabolic disease treatment are developed.
|
|
| Locked | Locked | Locked |
Surgical access tool for obesity and diabetes treatment is developed.
|
|
| Locked | Locked | Locked |
Developer of device for controlling hormonal balance
|
|
| Locked | Locked | Locked |
Developer of therapeutic formulation for treating diabetes
|
Detailed competitors of MetaModix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metamodix
Complete news archive for MetaModix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MetaModix
MetaModix was founded in 2009 and raised its 1st funding round 1 year after it was founded.
MetaModix is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
MetaModix is a funded company, having raised a total of $5.21M across 10 funding rounds to date.
MetaModix manufactures surgical and medical instruments for the treatment of metabolic disease and Type II diabetes. The company is developing a drug-free, nonsurgical therapy that eliminates symptoms and reduces weight in obese and overweight people with Type II Diabetes. The device is an implant that is attached between the small intestine and the stomach. It diverts digestive fluids from the pancreas and liver to flow around it without mixing with food thus mimicing the effects of gastric bypass procedure endoscopically without the costs or risks associated with surgery.
MetaModix's top competitors include Fractyl, GI Dynamics and EndObetes.
MetaModix offers EndoSleeve.